Mandy van Brakel

458 total citations
15 papers, 323 citations indexed

About

Mandy van Brakel is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Mandy van Brakel has authored 15 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Immunology and 3 papers in Genetics. Recurrent topics in Mandy van Brakel's work include CAR-T cell therapy research (10 papers), Immunotherapy and Immune Responses (9 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Mandy van Brakel is often cited by papers focused on CAR-T cell therapy research (10 papers), Immunotherapy and Immune Responses (9 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Mandy van Brakel collaborates with scholars based in Netherlands, Belgium and Switzerland. Mandy van Brakel's co-authors include Reno Debets, Paola Allavena, Imran Siddiqui, Marco Erreni, C. B. H. W. Lamers, Stefan Sleijfer, Pierre G. Coulie, André Kunert, Erik van Schooten and Joachim G.J.V. Aerts and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Cancer Research.

In The Last Decade

Mandy van Brakel

14 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mandy van Brakel Netherlands 10 248 179 88 50 46 15 323
Liora M. Schultz United States 10 347 1.4× 202 1.1× 132 1.5× 77 1.5× 73 1.6× 41 455
Won‐Ju Kim South Korea 10 180 0.7× 203 1.1× 152 1.7× 53 1.1× 63 1.4× 23 414
Linda C. Sandin Sweden 11 390 1.6× 360 2.0× 88 1.0× 57 1.1× 59 1.3× 16 546
Maryann Mikucki United States 4 312 1.3× 314 1.8× 131 1.5× 25 0.5× 40 0.9× 5 467
Xiaoli Tian China 11 199 0.8× 117 0.7× 107 1.2× 35 0.7× 63 1.4× 15 316
Zea Melton United States 7 165 0.7× 120 0.7× 113 1.3× 28 0.6× 42 0.9× 8 288
Tomasz Zabinski United Kingdom 6 279 1.1× 166 0.9× 84 1.0× 84 1.7× 101 2.2× 9 377
Domenico Orlando Italy 7 171 0.7× 112 0.6× 133 1.5× 54 1.1× 61 1.3× 8 299
Esther Schoutrop Sweden 7 170 0.7× 114 0.6× 69 0.8× 33 0.7× 45 1.0× 8 274
Donghua Shi China 5 254 1.0× 158 0.9× 68 0.8× 42 0.8× 55 1.2× 7 353

Countries citing papers authored by Mandy van Brakel

Since Specialization
Citations

This map shows the geographic impact of Mandy van Brakel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mandy van Brakel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mandy van Brakel more than expected).

Fields of papers citing papers by Mandy van Brakel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mandy van Brakel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mandy van Brakel. The network helps show where Mandy van Brakel may publish in the future.

Co-authorship network of co-authors of Mandy van Brakel

This figure shows the co-authorship network connecting the top 25 collaborators of Mandy van Brakel. A scholar is included among the top collaborators of Mandy van Brakel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mandy van Brakel. Mandy van Brakel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Seynhaeve, Ann L.B., Conny van Holten-Neelen, Rutger W. W. Brouwer, et al.. (2025). CXCL10 Secreted by Pericytes Mediates TNFα-Induced Vascular Leakage in Tumors and Enhances Extravasation of Nanoparticle-Based Chemotherapeutics. Cancer Research. 85(9). 1596–1610. 3 indexed citations
2.
Robbrecht, Debbie, Mandy van Brakel, Joost L. Boormans, et al.. (2022). A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancer. Cancer Immunology Immunotherapy. 72(3). 759–767. 9 indexed citations
3.
Brakel, Mandy van, et al.. (2022). Gene Engineering T Cells with T-Cell Receptor for Adoptive Therapy. Methods in molecular biology. 2453. 209–229.
4.
With, Mirjam de, Daan P. Hurkmans, Esther Oomen‐de Hoop, et al.. (2021). Germline Variation in PDCD1 Is Associated with Overall Survival in Patients with Metastatic Melanoma Treated with Anti-PD-1 Monotherapy. Cancers. 13(6). 1370–1370. 9 indexed citations
5.
6.
Lamers, C. B. H. W., Mandy van Brakel, Cor Berrevoets, et al.. (2020). Adoptive therapy with TCR gene-engineered T cells to treat patients with MAGE-C2-positive melanoma and head and neck cancer. Cytotherapy. 22(5). S128–S128. 1 indexed citations
7.
Brakel, Mandy van, et al.. (2019). Lack of B and T cell reactivity towards IDH1R132H in blood and tumor tissue from LGG patients. Journal of Neuro-Oncology. 144(1). 79–87. 12 indexed citations
8.
Kunert, André, Edwin A. Basak, Daan P. Hurkmans, et al.. (2019). CD45RA+CCR7− CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab. Journal for ImmunoTherapy of Cancer. 7(1). 149–149. 43 indexed citations
9.
Siddiqui, Imran, Marco Erreni, Mandy van Brakel, Reno Debets, & Paola Allavena. (2016). Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient. Journal for ImmunoTherapy of Cancer. 4(1). 21–21. 91 indexed citations
10.
Brakel, Mandy van, Sara Zalba, Erik van Schooten, et al.. (2016). Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody. International Journal of Nanomedicine. 11. 955–955. 30 indexed citations
11.
Kunert, André, Mandy van Brakel, Pierre G. Coulie, et al.. (2016). MAGE-C2–Specific TCRs Combined with Epigenetic Drug-Enhanced Antigenicity Yield Robust and Tumor-Selective T Cell Responses. The Journal of Immunology. 197(6). 2541–2552. 24 indexed citations
12.
Lamers, C. B. H. W., et al.. (2014). T Cell Receptor-Engineered T Cells to Treat Solid Tumors: T Cell Processing Toward Optimal T Cell Fitness. Human Gene Therapy Methods. 25(6). 345–357. 23 indexed citations
13.
Govers, Coen, Zsolt Sebestyén, Jason Roszik, et al.. (2014). TCRs Genetically Linked to CD28 and CD3ε Do Not Mispair with Endogenous TCR Chains and Mediate Enhanced T Cell Persistence and Anti-Melanoma Activity. The Journal of Immunology. 193(10). 5315–5326. 38 indexed citations
14.
Straetemans, Trudy, Mandy van Brakel, Joost Drexhage, et al.. (2012). TCR Gene Transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 Epitopes as Melanoma-Specific Immune Targets. SHILAP Revista de lepidopterología. 2012. 1–14. 36 indexed citations
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liora M. Schultz Breakdown of academic impact, for papers by Won‐Ju Kim Breakdown of academic impact, for papers by Linda C. Sandin Breakdown of academic impact, for papers by Maryann Mikucki Breakdown of academic impact, for papers by Xiaoli Tian Breakdown of academic impact, for papers by Zea Melton Breakdown of academic impact, for papers by Tomasz Zabinski Breakdown of academic impact, for papers by Domenico Orlando Breakdown of academic impact, for papers by Esther Schoutrop Breakdown of academic impact, for papers by Donghua Shi
Rankless by CCL
2026